Literature DB >> 21318568

Duration of post-surgical antibiotic therapy for adult chronic osteomyelitis: a single-centre experience.

Thierry Rod-Fleury1, Nathalie Dunkel, Mathieu Assal, Peter Rohner, Phedon Tahintzi, Louis Bernard, Pierre Hoffmeyer, Daniel Lew, Ilker Uçkay.   

Abstract

PURPOSE: The optimal duration of concomitant antibiotic therapy after surgical intervention for implant-free chronic osteomyelitis is unknown. No randomized data exist. Available recommendations are based on expert's opinion. We evaluated the duration of post-surgical antibiotic treatment related to remission of chronic osteomyelitis.
METHODS: This was a retrospective single-centre study at Geneva University Hospitals with a minimal follow-up of two years after treatment. We used multivariate logistic regression analysis with exclusion of pediatric cases and of implant-related chronic osteomyelitis.
RESULTS: A total of 49 episodes of implant-free chronic osteomyelitis in 49 adult patients were studied. The median number of surgical interventions was two (range, 1-10). The median duration of post-debridement antibiotic treatment was eight weeks (range, 4-14 weeks). Thirty-nine patients (80%) were in remission after a minimal follow-up of two years. In multivariate logistic regression analysis, one week of intravenous therapy had the same remission as two to three weeks (0.2, 0.1-1.9) or ≥ 3 weeks (0.3, 0.1-2.4). More than six weeks of total antibiotic treatment equalled ≤  six weeks (0.8, 0.1-5.2).
CONCLUSIONS: In chronic osteomyelitis in adults, a post-debridement antibiotic therapy beyond six weeks, or an IV treatment longer than one week, did not show enhanced remission incidences. Prospective randomized trials are required to confirm this observation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21318568      PMCID: PMC3193950          DOI: 10.1007/s00264-011-1221-y

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  23 in total

1.  Relaxing the rule of ten events per variable in logistic and Cox regression.

Authors:  Eric Vittinghoff; Charles E McCulloch
Journal:  Am J Epidemiol       Date:  2006-12-20       Impact factor: 4.897

2.  Recurrent osteomyelitis caused by infection with different bacterial strains without obvious source of reinfection.

Authors:  Ilker Uçkay; Mathieu Assal; Laurence Legout; Peter Rohner; Richard Stern; Daniel Lew; Pierre Hoffmeyer; Louis Bernard
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

Review 3.  Duration of post-surgical antibiotics in chronic osteomyelitis: empiric or evidence-based?

Authors:  Rachid Haidar; Asdghig Der Boghossian; Bisharah Atiyeh
Journal:  Int J Infect Dis       Date:  2010-05-14       Impact factor: 3.623

4.  Cierny-Mader Type III chronic osteomyelitis: the results of patients treated with debridement, irrigation, vancomycin beads and systemic antibiotics.

Authors:  Hakan Kinik; Mert Karaduman
Journal:  Int Orthop       Date:  2007-03-21       Impact factor: 3.075

5.  The treatment of chronic open osteomyelitis of the tibia in adults.

Authors:  Rodney K Beals; Richard E Bryant
Journal:  Clin Orthop Relat Res       Date:  2005-04       Impact factor: 4.176

6.  Outcome of management of chronic osteomyelitis at National Orthopaedic Hospital, Enugu.

Authors:  G O Eyichukwu; U E Anyaehie
Journal:  Niger J Med       Date:  2009 Apr-Jun

7.  Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years.

Authors:  Philippa C Matthews; Christopher P Conlon; Anthony R Berendt; Jill Kayley; Lorrayne Jefferies; Bridget L Atkins; Ivor Byren
Journal:  J Antimicrob Chemother       Date:  2007-06-11       Impact factor: 5.790

Review 8.  Antibiotics for treating chronic osteomyelitis in adults.

Authors:  Lucieni O Conterno; Carlos Rodrigues da Silva Filho
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

9.  Oral antibiotics are effective for highly resistant hip arthroplasty infections.

Authors:  José Cordero-Ampuero; Jaime Esteban; Eduardo García-Cimbrelo
Journal:  Clin Orthop Relat Res       Date:  2009-03-31       Impact factor: 4.176

10.  Free vascularised fibular grafting in the treatment of large skeletal defects due to osteomyelitis.

Authors:  Yuan Sun; Changqing Zhang; Dongxu Jin; Jiagen Sheng; Xiangguo Cheng; Xudong Liu; Shengbao Chen; Bingfang Zeng
Journal:  Int Orthop       Date:  2009-03-24       Impact factor: 3.075

View more
  15 in total

1.  Chronic osteomyelitis.

Authors:  Ilker Uçkay; Kheeldass Jugun; Axel Gamulin; Joe Wagener; Pierre Hoffmeyer; Daniel Lew
Journal:  Curr Infect Dis Rep       Date:  2012-10       Impact factor: 3.725

2.  Variables associated with remission in spinal surgical site infections.

Authors:  Julien Billières; Ilker Uçkay; Antonio Faundez; Jonathan Douissard; Paulina Kuczma; Domizio Suvà; Mathieu Zingg; Pierre Hoffmeyer; Dennis E Dominguez; Guillaume Racloz
Journal:  J Spine Surg       Date:  2016-06

3.  Remission rate of implant-related infections following revision surgery after fractures.

Authors:  Mohamed Al-Mayahi; Michael Betz; Daniel A Müller; Richard Stern; Phedon Tahintzi; Louis Bernard; Pierre Hoffmeyer; Domizio Suvà; Ilker Uçkay
Journal:  Int Orthop       Date:  2013-09-20       Impact factor: 3.075

4.  Coating with a novel gentamicinpalmitate formulation prevents implant-associated osteomyelitis induced by methicillin-susceptible Staphylococcus aureus in a rat model.

Authors:  Christian Fölsch; Maike Federmann; Klaus D Kuehn; Clemens Kittinger; Stefan Kogler; Gernot Zarfel; Martina Kerwat; Steve Braun; Susanne Fuchs-Winkelmann; Jürgen R J Paletta; Philip P Roessler
Journal:  Int Orthop       Date:  2014-11-08       Impact factor: 3.075

Review 5.  Systemic antibiotic therapy for chronic osteomyelitis in adults.

Authors:  Brad Spellberg; Benjamin A Lipsky
Journal:  Clin Infect Dis       Date:  2011-12-12       Impact factor: 9.079

6.  Factors predictive of relapse in adult bacterial osteomyelitis of long bones.

Authors:  E Garcia Del Pozo; J Collazos; J A Carton; D Camporro; V Asensi
Journal:  BMC Infect Dis       Date:  2018-12-07       Impact factor: 3.090

Review 7.  Charcot foot and ankle with osteomyelitis.

Authors:  Ryan Donegan; Bauer Sumpio; Peter A Blume
Journal:  Diabet Foot Ankle       Date:  2013-10-01

8.  Pressure ulcer-related pelvic osteomyelitis: evaluation of a two-stage surgical strategy (debridement, negative pressure therapy and flap coverage) with prolonged antimicrobial therapy.

Authors:  Johan Andrianasolo; Tristan Ferry; Fabien Boucher; Joseph Chateau; Hristo Shipkov; Fatiha Daoud; Evelyne Braun; Claire Triffault-Fillit; Thomas Perpoint; Frédéric Laurent; Alain-Ali Mojallal; Christian Chidiac; Florent Valour
Journal:  BMC Infect Dis       Date:  2018-04-10       Impact factor: 3.090

9.  Chronic Osteomyelitis - Bacterial Flora, Antibiotic Sensitivity and Treatment Challenges.

Authors:  Kuzma Jerzy; Hombhanje Francis
Journal:  Open Orthop J       Date:  2018-03-30

10.  Bacterial osteomyelitis: microbiological, clinical, therapeutic, and evolutive characteristics of 344 episodes.

Authors:  E García Del Pozo; J Collazos; J A Cartón; D Camporro; V Asensi
Journal:  Rev Esp Quimioter       Date:  2018-05-11       Impact factor: 1.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.